Arnold DL - Search Results

1

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.

Reich DS, Arnold DL, Vermersch P, Bar-Or A, Fox RJ, Matta A, Turner T, Wallström E, Zhang X, Mareš M, Khabirov FA, Traboulsee A; Tolebrutinib Phase 2b Study Group. Reich DS, et al. Among authors: arnold dl. Lancet Neurol. 2021 Sep;20(9):729-738. doi: 10.1016/S1474-4422(21)00237-4. Lancet Neurol. 2021. PMID: 34418400 Free PMC article. Clinical Trial.

2

Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.

Matthews PM, Francis G, Antel J, Arnold DL. Matthews PM, et al. Among authors: arnold dl. Neurology. 1991 Aug;41(8):1251-6. doi: 10.1212/wnl.41.8.1251. Neurology. 1991. PMID: 1650931

3

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, Antel JP. Arnold DL, et al. Ann Neurol. 1994 Jul;36(1):76-82. doi: 10.1002/ana.410360115. Ann Neurol. 1994. PMID: 8024266

4

Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy.

Matthews PM, Pioro E, Narayanan S, De Stefano N, Fu L, Francis G, Antel J, Wolfson C, Arnold DL. Matthews PM, et al. Among authors: arnold dl. Brain. 1996 Jun;119 ( Pt 3):715-22. doi: 10.1093/brain/119.3.715. Brain. 1996. PMID: 8673485

5

Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.

Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, Antel JP, Matthews PM, Arnold DL. Narayanan S, et al. Among authors: arnold dl. Ann Neurol. 1997 Mar;41(3):385-91. doi: 10.1002/ana.410410314. Ann Neurol. 1997. PMID: 9066360 Clinical Trial.

6

Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient.

De Stefano N, Matthews PM, Narayanan S, Francis GS, Antel JP, Arnold DL. De Stefano N, et al. Among authors: arnold dl. Neurology. 1997 Oct;49(4):1138-41. doi: 10.1212/wnl.49.4.1138. Neurology. 1997. PMID: 9339704

7

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, Antel JP, Arnold DL. De Stefano N, et al. Among authors: arnold dl. Brain. 1998 Aug;121 ( Pt 8):1469-77. doi: 10.1093/brain/121.8.1469. Brain. 1998. PMID: 9712009

8

Relating axonal injury to functional recovery in MS.

Reddy H, Narayanan S, Matthews PM, Hoge RD, Pike GB, Duquette P, Antel J, Arnold DL. Reddy H, et al. Among authors: arnold dl. Neurology. 2000 Jan 11;54(1):236-9. doi: 10.1212/wnl.54.1.236. Neurology. 2000. PMID: 10636158

9

Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume.

Prat A, Pelletier D, Duquette P, Arnold DL, Antel JP. Prat A, et al. Among authors: arnold dl. Ann Neurol. 2000 Feb;47(2):234-7. Ann Neurol. 2000. PMID: 10665495

10

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

Narayanan S, De Stefano N, Francis GS, Arnaoutelis R, Caramanos Z, Collins DL, Pelletier D, Arnason BGW, Antel JP, Arnold DL. Narayanan S, et al. Among authors: arnold dl. J Neurol. 2001 Nov;248(11):979-86. doi: 10.1007/s004150170052. J Neurol. 2001. PMID: 11757963 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

530 results

Search Page